{Reference Type}: Journal Article
{Title}: Cracking the NLRP3 code: Pioneering precision medicine for inflammation.
{Author}: Weber ANR;Tortola MM;Kuemmerle-Deschner JB;
{Journal}: J Exp Med
{Volume}: 221
{Issue}: 5
{Year}: 2024 May 6
{Factor}: 17.579
{DOI}: 10.1084/jem.20240221
{Abstract}: Precisely diagnosing and effectively treating cryopyrin-associated periodic syndrome (CAPS), an inflammatory condition linked to gain-of-function NLRP3 inflammasome mutations, poses challenges. A novel classification approach may help inform therapeutic decisions and offer valuable insights into broader inflammatory conditions (Cosson et al. J. Exp. Med. 2024. https://doi.org/10.1084/jem.20231200).